-->

Type something and hit enter

By On
advertise here
 Type 2 diabetes is an antidiabetic medicine that is more than lower blood sugar. -2

According to Journal of Diabetes Research, In February 2018, the use of exenatide against diabetics (Byetta, Bydureon) increases blood sugar levels. It can also be used to reduce abdominal fat.

Researchers at Suzhou University in Jiangsu Province, China, turned to 20 newly diagnosed type 2 diabetes with exenatide. Diabetics have shown improvement ...

  • insulin sensitivity
  • improve blood fats and
  • redistribution of fat from the central region of the abdomen.
The researchers concluded that exenatide could be used to help redistribute excess fat away from the abdominal area.

Although it is the perfect solution to avoid obesity or being overweight, abdominal fat should be avoided as it is especially dangerous. Fat in other parts of the body is under the skin, but abdominal fat spreads deeper among and around the organs. Fat cells in the abdominal area make a lot of hormones and other molecules that affect inflammation, energy storage and metabolism. The main body forms are often described mainly as an apple and a pear ...

  • An apple-shaped body carries most of its weight near the center.
  • pear-shaped bodies, as a rule, have smaller waists and have more weight on the hips.
Apple-shaped bodies are considered to have a higher risk of developing type 2 diabetes, heart disease, and metabolic syndrome.

The American Heart Association defines abdominal obesity as a measure of the waist ...

  • over 88 centimeters (35 inches) in women and
  • more than 102 centimeters (40 inches) in men.
The International Diabetes Foundation defines the condition ...

  • measuring waist sizes over 80 centimeters (35 inches) in women and
  • more than 90 centimeters (35.5 inches) in men.
The World Health Organization uses the waist to hip ratio. Measuring waist and hips is considered abdominal obesity, as more than 0.85 in women and more than 0.9 in men.

Exenatide (Byetta) is a member of the incretin-mimetic family and reduces blood sugar by ...

  • causing the pancreas to release more insulin when necessary,
  • slowing gastric emptying, so sugar is slowly released into the blood,
  • not allowing the liver to release too much sugar and
  • helping to reduce appetite.
Other members of the incremental mimetic family include ...

  • Victoza,
  • Saxenda
  • Trulicity
  • Tanzeum,
  • Adlyxin
  • Ozempic
Possible side effects ...

  • diarrhea,
  • nausea,
  • vomiting
  • headache,
  • dizziness,
  • increased sweating
  • indigestion and
  • constipation.
Epidemics of overweight and obesity. The increase in type 2 diabetes is accompanied by an increase in obesity and body mass index (BMI) over the past ten years ...

  • according to the Centers for Disease Control and Prevention (CDC) in the United States, more than a third of American adults are obese.
  • The World Health Organization (WHO) said in 2016 that more than 1.9 billion adults, 18 years and older, are overweight or obese.
Adult obesity is growing at an alarming rate in most western countries. Worldwide, it has been found that around the world, about 11 percent of men and 15 percent of women are obese.




 Type 2 diabetes is an antidiabetic medicine that is more than lower blood sugar. -2


 Type 2 diabetes is an antidiabetic medicine that is more than lower blood sugar. -2

Click to comment